Emerging antibody-based therapeutics against SARS-CoV-2 during the global pandemic is a research paper published in Antibody Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 45 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI CCR Antibody Engineering Program
Grant: ZIC BC 011891
National Cancer Institute
Grant: ZIA BC010891
National Cancer Institute
Grant: Z01 BC010891
NIH Intramural Targeted Anti-COVID-19 (ITAC) Program
Grant: ZIA BC 011943
Intramural NIH HHS
Grant: Z99 CA999999
Intramural Research Program of NIH
Center for Cancer Research
Influential Citations
4
Fields of Study
Keywords
Additional file 2 of Rapid, simple, and effective strategy to produce monoclonal antibodies targeting protein structures using hybridoma technology
Additional file 2 of Rapid, simple, and effective strategy to produce monoclonal antibodies targeting protein structures using hybridoma technology
Additional file 1 of Rapid, simple, and effective strategy to produce monoclonal antibodies targeting protein structures using hybridoma technology
Additional file 1 of Rapid, simple, and effective strategy to produce monoclonal antibodies targeting protein structures using hybridoma technology